US Patent Issued to SHANGHAI ZHONGZE THERAPEUTICS, SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY on Sept. 9 for "Pyridinyl morpholine compound, preparation method therefor, and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,136, issued on Sept. 9, was assigned to SHANGHAI ZHONGZE THERAPEUTICS Co. LTD. (Shanghai) and SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (Shanghai).

"Pyridinyl morpholine compound, preparation method therefor, and application thereof" was invented by Jianqi Li (Shanghai), Yangli Qi (Shanghai), Xiaowen Chen (Shanghai), Junwei Xu (Shanghai), Ruixiang Yuan (Shanghai) and Qiang Pu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the present invention are a pyridinyl morpholine compound, a preparation method therefor, and an application thereof. The present invention provides a pyridinyl morpholine compound as represented by form...